The Minkui Luo Lab: Publications


Visit PubMed for a full listing of Minkui Luo’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Xiao Shu, Qing Dai, Tong Wu, Ian R. Bothwell, Yanan Yue, Zezhou Zhang, Jie Cao, Qili Fei, Minkui Luo, Chuan He, and Jianzhao Liu, “N6-Allyladenosine: A New Small Molecule for RNA Labeling Identified by Mutation Assay”, J. Am. Chem. Soc. 2017, 139, 17213.

Joshua A. Linscott, Kanishk Kapilashrami, Zhen Wang, Chamara Senevirathne, Ian R. Bothwell, Gil Blum, Minkui Luo, “Kinetic Isotope Effects Reveal Early SN2 Transition State of SET8-catalyzed Protein Lysine Methylation”, Proc. Natl. Acad. Sci. U.S.A. 2016, 113, E8369.

Butler, Kyle V.; Ma, Anqi; Yu, Wenyu; Li, Fengling; Pittella-Silva, Fabio; Organ, Shawna L. ; Tempel, Wolfram; Babault, Nicolas; Shao, Jason; Wang, Junyi; Barsyte-Lovejoy, Dalia; Vedadi, Masoud; Luo, Minkui; Brown, Peter; Arrowsmith, Cheryl H.; Jin, Jian, “Structure Based Design of Covalent Inhibitors of the SETD8 Protein Lysine Methyltransferase”, J. Med. Chem. 2016, 59, 9881.

Wu H, Zheng W, Eram MS, Vhuiyan M, Dong A, Zeng H, He H, Brown P, Frankel A, Vedadi M, Luo M, Min J., “Structural basis of asymmetrical dimethylation by PRMT6”, Biochem J. 2016, 473, 3049.

Warrier T, Kapilashrami K, Argyrou A, Ioerger T, Little D, Murphy K, Nandakumar M, Park S, Gold B, Mi J, Zhang T, Meiler E, Rees M, Somersan-Karakaya S, Francisco EP, Martinez-Hoyos M, Burns-Huang K, Roberts J, Ling Y, Rhee K, Mendoza-Losana A, Luo M, Carl Nathan C, “N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis”, Proc. Natl. Acad. Sci. U.S.A. 2016, 113, E4523. This paper was featured by Today’s Science Sparks at MSKCC.

Tang H, Chen Y, Liu X, Wang S, Lv Y, Wu D, Wang Q, Luo M, Deng H, “Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma”, Oncotarget. 2016, 7, 38822.

LaFave LM, Béguelin W, Koche R, Teater M, Spitzer B, Chramiec A, Papalexi E, Keller MD, Hricik T, Konstantinoff K, Micol JB, Durham B, Knutson SK, Campbell JE, Blum G, Shi X, Doud EH, Krivtsov AV, Chung YR, Khodos I, de Stanchina E, Ouerfelli O, Adusumilli PS, Thomas PM, Kelleher NL, Luo M, Keilhack H, Abdel-Wahab O, Melnick A, Armstrong SA, Levine RL, “Reply to ‘Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status’”, Nat. Med., 2016, 22, 578.

Tang H, Li J, Liu X, Wang G, Luo M, Deng H, “Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway”, Sci. Rep., 2016, 6, 28388.